Best Medical Oncologists for Multiple Myeloma in India

Multiple myeloma is a cancer in which abnormal plasma cells accumulate in the bone marrow, producing excess proteins (called M-proteins or paraproteins) that can damage organs and disrupt normal blood cell production. It is considered a haematological malignancy and, while not currently curable in most cases, it is treatable and can often be managed effectively for many years.

Common symptoms include persistent bone pain (particularly in the back, ribs, or hips), unexplained fatigue, frequent infections, easy bruising or bleeding, and signs of kidney problems such as increased thirst or reduced urine output. Some people experience numbness or weakness in the limbs if the disease affects the spine, and elevated calcium levels can cause confusion, nausea, or constipation. These symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis of multiple myeloma.

Diagnosis typically involves blood and urine tests to detect abnormal proteins (including serum protein electrophoresis, immunofixation, and free light chain assay), a full blood count, kidney and calcium level checks, and bone marrow biopsy to confirm the presence and proportion of malignant plasma cells. Imaging — such as whole-body low-dose CT, MRI, or PET-CT — is used to assess bone involvement and detect lesions. Disease severity is stratified using established staging systems such as the Revised International Staging System (R-ISS), which incorporates albumin, beta-2 microglobulin, LDH levels, and cytogenetic risk markers to guide prognosis and treatment decisions.

Treatment is highly individualised and depends on factors including disease stage, cytogenetic risk profile, the patient's age, fitness, and organ function. For eligible patients, high-dose chemotherapy followed by autologous stem cell transplantation (using the patient's own stem cells) is a standard approach that can deepen and prolong remission. Alongside or instead of transplant, treatment may include combinations of targeted therapies (such as proteasome inhibitors or IMiDs), immunotherapy (including monoclonal antibodies), and conventional chemotherapy, with the specific regimen determined by a qualified specialist based on individual assessment.

For patients who are not eligible for stem cell transplantation — due to age, fitness level, or other health conditions — effective non-procedural management is available using combinations of oral or intravenous targeted agents, immunotherapy, and chemotherapy. Supportive care measures, including bisphosphonates to protect bone health, growth factors to address anaemia, and prophylactic antibiotics to reduce infection risk, form an important part of ongoing management for all patients regardless of transplant eligibility. Active monitoring (sometimes called 'watch and wait') may be appropriate for asymptomatic precursor states such as smouldering myeloma, but this decision must be made by a specialist following careful individual assessment.

Autologous Bone Marrow Transplant may be considered when conservative or medical options have not achieved enough improvement, or when the severity of the condition warrants it. The decision depends on clinical assessment, expected benefits and individual risks.

Multiple myeloma is typically evaluated and managed by a haematologist or medical oncologist with specific expertise in haematological malignancies. For patients being considered for stem cell transplantation, care is coordinated through a specialist in bone marrow transplantation, usually within a multidisciplinary team that may also include nephrologists, radiologists, and specialist nurses.

When selecting a specialist or facility, it is worth asking about the centre's volume and experience specifically in treating multiple myeloma, whether they offer access to a full multidisciplinary team, availability of novel and clinical-trial therapies, and what structured follow-up and relapse monitoring looks like over the long term.

Share a medical summary, investigation and imaging or biopsy reports where relevant, a current medication list, previous diagnoses and related treatment records. Provide clear copies with translation where needed.

Our care coordination team helps review initial medical information, connect you with suitable doctors and hospitals, explain next steps and indicative estimates, and organise a treatment plan before travel.